GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (NSE:CONCORDBIO) » Definitions » Inventories, Raw Materials & Components

Concord Biotech (NSE:CONCORDBIO) Inventories, Raw Materials & Components : ₹0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Inventories, Raw Materials & Components?

Concord Biotech's inventories, raw materials & components for the quarter that ended in Dec. 2024 was ₹0 Mil.

Concord Biotech's annual raw materials increased from Mar. 2022 (₹827 Mil) to Mar. 2023 (₹843 Mil) but then declined from Mar. 2023 (₹843 Mil) to Mar. 2024 (₹679 Mil).


Concord Biotech Inventories, Raw Materials & Components Historical Data

The historical data trend for Concord Biotech's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Inventories, Raw Materials & Components Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Inventories, Raw Materials & Components
618.89 652.19 827.49 843.15 678.76

Concord Biotech Quarterly Data
Mar20 Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 678.76 - - -

Concord Biotech Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Concord Biotech Business Description

Industry
Traded in Other Exchanges
Address
Iscon Cross Road, S.G. Highway, B-1601-1602, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products.

Concord Biotech Headlines

No Headlines